Research Data for ABBI

Enter Symbol

Company Profile

Technical Charts

Analyst Ratings

Analyst Estimates

Sales Estimates

Whisper Estimates

Enter Estimates

Press Releases

Financial Ratios

Sector: MedicalABRAXIS BIOSCIENCE (NASDAQ:ABBI)

ABBI Ranking Chart

1m
3m
6m
1y
2y
5Y

Sentiment Survey

Average Short Term

Average Long Term

Investment Grade

Ranking History (Scroll mouse over rank for more information)

Rating Date: 11/19/2008 Rating: B

Headlines

Abraxis Given China Approval for Cancer Drug ABRAXANE
Jul 15, 2008 06:24 PM
NASDAQ Technical Picture - Bulls Regain Momentum
Aug 09, 2007 02:15 AM
Abraxis BioScience to Host R&D Investor Day and GlaxoSmithKline Gets New FDA Hycamtin OK
Jun 16, 2006 12:01 PM
Pfizer Shares Rise After Viagra Patent Win and Glaxo HPV vaccine shows promise for women 26-55
Jun 06, 2006 11:01 AM
Abraxis BioScience Bolsters Manufacturing and Global Operational Expertise With Key Senior Executives and Wyeth Releases Study on Antidepressant
May 26, 2006 11:01 AM

Analyst Ratings

ABBI Analyst Chart

Share Performance

Period	ABBI	Compare to S&P
YTD	-21.47 %	-22.42 %
4 Weeks	-10.54 %	-7.07 %
12 Weeks	0.75 %	-1.56 %
More...

Financial Ratios

ABBI Financial Ratios Chart

Earnings Performance

EPS Growth in Last Quarter: -47.83 %

EPS Growth in Last Year: -33.33 %

Sales Growth in Last Quarter: -0.65 %

Sales Growth in Last Quarter: 18.62 %

Top Tickers

Home | Login |Research | Earnings | Scans | Chat Rooms | Charts | Submit Article | Join Blog Network | Contributors |

Subscribe to RSS

copryright 2008 all rights reserved